Impact Health is a mission-driven health policy and strategic consulting firm dedicated to improving health and well-being for all.
OUR SERVICES
Strategic Planning
Integrate mission-aligned policy expertise and political acumen into planning and executing your goals.
Government Contracting
Track record of success supporting states and municipalities in innovating or launching new programs.
Our proprietary method for tracking, aggregating, and analyzing state policy trends.
If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Agency Issues State Medicaid Letter Giving States an Optional Six Months Hold Harmless Period for Work Requirements Implementation
The Centers for Medicare and Medicaid Services issued a State Medicaid Director letter introducing an optional six month hold-harmless period available to all states as they implement the new Medicaid work requirements. CMS reminds states that work requirements are scheduled to go into effect January 1, 2027, and notes that states have been making substantial progress towards implementing these requirements…. (Marceno, November 13, 2026) #Insurance Coverage, #Medicaid, #Public Health
Department Announces New Investments to Advance Psychedelic Research, Including Ibogaine Development and Rapid-Acting Mental Health Treatments
The Department of Health and Human Services (HHS) announced two initiatives to advance research into psychedelic and other rapid-acting therapies for serious mental illness. The announcement includes an Advanced Research Projects Agency for Health (ARPA-H) investment of up to $4.9 million over five years to establish the scientific, regulatory, and manufacturing foundation for future U.S. clinical trials of ibogaine, particularly… (Colocho, November 13, 2026) #Grants, #Mental and Behavioral Health, #National Institutes of Health



